These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37949444)

  • 21. Effectiveness of intensive adherence counselling in achieving an undetectable viral load among people on antiretroviral therapy with low-level viraemia in Uganda.
    Nanyeenya N; Nakanjako D; Makumbi F; Nakigozi G; Nalugoda F; Kigozi G; Nasuuna E; Kibira SPS; Nabadda S; Kiyaga C; Huzaifah M; Kiwanuka N
    HIV Med; 2024 Feb; 25(2):245-253. PubMed ID: 37853605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early infant diagnosis HIV-1 PCR cycle-threshold predicts infant viral load at birth.
    Haeri Mazanderani A; Kufa T; Technau KG; Strehlau R; Patel F; Shiau S; Burke M; Kuhn L; Abrams EJ; Sherman GG;
    J Clin Virol; 2019 May; 114():21-25. PubMed ID: 30903987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of continuous quality improvement on coverage of antenatal HIV care tests in rural South Africa: Results of a stepped-wedge cluster-randomised controlled implementation trial.
    Yapa HM; De Neve JW; Chetty T; Herbst C; Post FA; Jiamsakul A; Geldsetzer P; Harling G; Dhlomo-Mphatswe W; Moshabela M; Matthews P; Ogbuoji O; Tanser F; Gareta D; Herbst K; Pillay D; Wyke S; Bärnighausen T
    PLoS Med; 2020 Oct; 17(10):e1003150. PubMed ID: 33027246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Linkage to care, mobility and retention of HIV-positive postpartum women in antiretroviral therapy services in South Africa.
    Phillips TK; Clouse K; Zerbe A; Orrell C; Abrams EJ; Myer L
    J Int AIDS Soc; 2018 Jul; 21 Suppl 4(Suppl Suppl 4):e25114. PubMed ID: 30027583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of HIV-Status Disclosure on HIV Viral Load in Pregnant and Postpartum Women on Antiretroviral Therapy.
    Brittain K; Mellins CA; Remien RH; Phillips TK; Zerbe A; Abrams EJ; Myer L
    J Acquir Immune Defic Syndr; 2019 Aug; 81(4):379-386. PubMed ID: 30939530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differentiated models of care for postpartum women on antiretroviral therapy in Cape Town, South Africa: a cohort study.
    Myer L; Iyun V; Zerbe A; Phillips TK; Brittain K; Mukonda E; Allerton J; Kalombo CD; Nofemela A; Abrams EJ
    J Int AIDS Soc; 2017 Jul; 20(Suppl 4):21636. PubMed ID: 28770593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acceptability of point-of-care viral load testing to facilitate differentiated care: a qualitative assessment of people living with HIV and nurses in South Africa.
    Msimango L; Gibbs A; Shozi H; Ngobese H; Humphries H; Drain PK; Garrett N; Dorward J
    BMC Health Serv Res; 2020 Nov; 20(1):1081. PubMed ID: 33239012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brief Report: Viral Load Monitoring in Pregnancy to Predict Peripartum Viremia in South Africa.
    Odayar J; Kabanda S; Malaba TR; Lesosky M; Myer L
    J Acquir Immune Defic Syndr; 2021 Sep; 88(1):6-9. PubMed ID: 34050102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population-level viral suppression among pregnant and postpartum women in a universal test and treat trial.
    Kabami J; Balzer LB; Saddiki H; Ayieko J; Kwarisiima D; Atukunda M; Charlebois ED; Clark TD; Koss CA; Ruel T; Bukusi EA; Cohen CR; Musoke P; Petersen ML; Havlir DV; Kamya MR; Chamie G
    AIDS; 2020 Jul; 34(9):1407-1415. PubMed ID: 32472768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV viral suppression and longevity among a cohort of children initiating antiretroviral therapy in Eastern Cape, South Africa.
    Teasdale CA; Sogaula N; Yuengling KA; Wang C; Mutiti A; Arpadi S; Nxele M; Pepeta L; Mogashoa M; Rivadeneira ED; Abrams EJ
    J Int AIDS Soc; 2018 Aug; 21(8):e25168. PubMed ID: 30094952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV viral load non-suppression and associated factors among pregnant and postpartum women in rural northeastern South Africa: a cross-sectional survey.
    Ngandu NK; Lombard CJ; Mbira TE; Puren A; Waitt C; Prendergast AJ; Tylleskär T; Van de Perre P; Goga AE
    BMJ Open; 2022 Mar; 12(3):e058347. PubMed ID: 35273061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinic-based SAMBA-II vs centralized laboratory viral load assays among HIV-1 infected children, adolescents and young adults in rural Zimbabwe: A randomized controlled trial.
    Kouamou V; Machekano R; Mapangisana T; Maposhere C; Mutetwa R; Manasa J; Shamu T; McCarty K; Munyati S; Mutsvangwa J; Bogoshi M; Israelski D; Katzenstein D
    PLoS One; 2023; 18(2):e0281279. PubMed ID: 36787296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-Term Outcomes of HIV-Infected Women Receiving Antiretroviral Therapy After Transferring Out of an Integrated Maternal and Child Health Service in South Africa.
    Phillips TK; Mogoba P; Brittain K; Gomba Y; Zerbe A; Myer L; Abrams EJ
    J Acquir Immune Defic Syndr; 2020 Mar; 83(3):202-209. PubMed ID: 31725060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protocol for a randomised feasibility study of Point-Of-care HIV viral load testing to Enhance Re-suppression in South Africa: the POwER study.
    Dorward J; Sookrajh Y; Ngobese H; Lessells R; Sayed F; Bulo E; Moodley P; Samsunder N; Lewis L; Tonkin-Crine S; Drain PK; Hayward G; Butler CC; Garrett N
    BMJ Open; 2021 Feb; 11(2):e045373. PubMed ID: 33593788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of undetectable and suppressed viral load in HIV-infected pregnant women initiating Option B+ in Uganda: an observational study nested within a randomized controlled trial.
    Gabagaya G; Rukundo G; Amone A; Wavamunno P; Namale-Matovu J; Lubega I; Nakabiito C; Namukwaya Z; Nolan M; Malamba SS; King R; Homsy J; Fowler MG; Musoke P
    BMC Infect Dis; 2021 Sep; 21(1):907. PubMed ID: 34481464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiretroviral Adherence, Elevated Viral Load, and Drug Resistance Mutations in Human Immunodeficiency Virus-infected Women Initiating Treatment in Pregnancy: A Nested Case-control Study.
    Myer L; Redd AD; Mukonda E; Lynch BA; Phillips TK; Eisenberg A; Hsiao NY; Capoferri A; Zerbe A; Clarke W; Lesosky M; Breaud A; McIntyre J; Bruno D; Martens C; Abrams EJ; Reynolds SJ
    Clin Infect Dis; 2020 Jan; 70(3):501-508. PubMed ID: 30877752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. "
    Nakyanzi A; Naddunga F; Bulterys MA; Mujugira A; Wyatt MA; Kamusiime B; Nalumansi A; Kasiita V; Peacock S; Celum CL; Ware NC
    Diagnostics (Basel); 2023 Dec; 14(1):. PubMed ID: 38201381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Switch to second-line versus continued first-line antiretroviral therapy for patients with low-level HIV-1 viremia: An open-label randomized controlled trial in Lesotho.
    Amstutz A; Nsakala BL; Vanobberghen F; Muhairwe J; Glass TR; Namane T; Mpholo T; Battegay M; Klimkait T; Labhardt ND
    PLoS Med; 2020 Sep; 17(9):e1003325. PubMed ID: 32936795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimal timing of viral load monitoring during pregnancy to predict viraemia at delivery in HIV-infected women initiating ART in South Africa: a simulation study.
    Lesosky M; Glass T; Mukonda E; Hsiao NY; Abrams EJ; Myer L
    J Int AIDS Soc; 2017 Nov; 20 Suppl 7(Suppl 7):. PubMed ID: 29171179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Viral load testing among pregnant women living with HIV in Mutare district of Manicaland province, Zimbabwe.
    Musanhu CCC; Takarinda KC; Shea J; Chitsike I; Eley B
    AIDS Res Ther; 2022 Nov; 19(1):52. PubMed ID: 36384677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.